Mack P F, Hass D, Lavyne M H, Snow R B, Lien C A
Anesthesiology, Weill Medical College of Cornell University, The New York Presbyterian Hospital, New York, New York 10021, USA.
Spine (Phila Pa 1976). 2001 Mar 15;26(6):658-61. doi: 10.1097/00007632-200103150-00021.
Prospective, randomized, double-blind study.
To assess the efficacy of ketorolac and bupivacaine in reducing postoperative pain after microsurgical lumbar discectomy.
Microsurgical lumbar discectomy often is performed as an ambulatory procedure. Pain, nausea, and urinary retention may delay discharge. It was hypothesized that intraoperative ketorolac or bupivacaine would reduce postoperative pain as measured by morphine demand.
After Institutional Review Board (IRB) approval and informed consent, 30 patients undergoing single-level microsurgical lumbar discectomy under general anesthesia randomly received either intravenous ketorolac, intramuscular bupivacaine, or placebo before wound closure. After surgery, all patients received intravenous, MSO4, patient-controlled analgesia. MSO4 demand was compared between groups at 30 minutes and at 1, 4, 8, 16, 20, and 24 hours after surgery by one-way ANOVA. Pre- and postoperative pain was assessed by using a standard scale and was correlated to postoperative MSO4 demand by Pearson correlation. Significance was assumed at P < 0.05.
There were no group differences in age, gender, weight, disc level, preoperative pain, or preoperative use of pain medication. Neither ketorolac nor bupivacaine decreased pain or nausea scores, MSO4 demand, or time to void and ambulation. Preoperative pain was significantly correlated to postoperative narcotic demand (r = 0.46, P < 0.01). Preoperative narcotic or NSAID use was not correlated to either preoperative pain scores or postoperative MSO4 requirement.
Neither ketorolac nor bupivacaine decreased the postoperative narcotic requirement in patients undergoing microsurgical lumbar discectomy. Postoperative narcotic requirements are increased in patients who are in severe pain before surgery, regardless of preoperative narcotic use.
前瞻性、随机、双盲研究。
评估酮咯酸和布比卡因在减轻显微腰椎间盘切除术后疼痛方面的疗效。
显微腰椎间盘切除术通常作为门诊手术进行。疼痛、恶心和尿潴留可能会延迟出院。据推测,术中使用酮咯酸或布比卡因可通过吗啡需求量来衡量减轻术后疼痛。
经机构审查委员会(IRB)批准并获得知情同意后,30例在全身麻醉下接受单节段显微腰椎间盘切除术的患者在伤口缝合前随机接受静脉注射酮咯酸、肌肉注射布比卡因或安慰剂。术后,所有患者均接受静脉注射硫酸吗啡自控镇痛。通过单因素方差分析比较术后30分钟以及术后1、4、8、16、20和24小时各组间的硫酸吗啡需求量。使用标准量表评估术前和术后疼痛,并通过Pearson相关性分析将其与术后硫酸吗啡需求量相关联。P < 0.05时具有统计学意义。
在年龄、性别、体重、椎间盘节段、术前疼痛或术前止痛药使用方面,各组之间无差异。酮咯酸和布比卡因均未降低疼痛或恶心评分、硫酸吗啡需求量或排尿和行走时间。术前疼痛与术后麻醉需求量显著相关(r = 0.46,P < 0.01)。术前使用麻醉药或非甾体抗炎药与术前疼痛评分或术后硫酸吗啡需求量均无相关性。
酮咯酸和布比卡因均未降低接受显微腰椎间盘切除术患者的术后麻醉需求量。术前疼痛严重的患者术后麻醉需求量增加,无论术前是否使用麻醉药。